Newsletter Subject

Colorado's Ban on 'Abortion Reversal' Tied Up in Court Battle

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Nov 2, 2023 10:52 PM

Email Preheader Text

Daily Headlines Thursday, November 02, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLI

[MEDPAGE TODAY]( Daily Headlines Thursday, November 02, 2023 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [Colorado's Ban on 'Abortion Reversal' Tied Up in Court Battle]( [NEUROLOGY]( [Brain Health Took a Hit During the COVID Pandemic]( [POP MEDICINE]( [Viral Medical Costumes; 'Nurses Are Not Safe'; The Joy of Pet Therapy]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Employing Tools in Clinical Practice to Accelerate Prompt, Accurate Diagnosis and Risk Assessment in MDS]( [RHEUMATOLOGY]( [JAK Inhibitor Safety Study Seen Altering Practice in the VA]( [PRIMARY CARE]( [Vape Use May Have Turned a Corner Among High Schoolers]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [CRITICAL CARE]( [Infectious Disease Groups Urge CMS to Retire Sepsis Treatment Guidelines]( CME SPOTLIGHT [Expanding Evaluation and Referral of Anemia in Primary Care Settings to Diagnose Underlying Myelodysplastic Syndromes]( [GASTROENTEROLOGY]( [New Option Approved for Erosive Esophagitis]( [RADIOLOGY]( [False-Positive Mammograms May Indicate Higher Breast Cancer Risk in the Future]( [MEETING COVERAGE]( [Eculizumab Substantially Reduces Myasthenia Gravis Events]( CME SPOTLIGHT [Applying the Latest Evidence for Anemia Management in Patients With Lower-Risk Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia]( [PUBLIC HEALTH & POLICY]( [Equal Representation of Indigenous Docs Would Take a Century, Study Finds]( [CASE STUDIES]( [Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis]( [MEETING COVERAGE]( [Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S.]( CME SPOTLIGHT [Navigating the Evolving Treatment Paradigm for Myelodysplastic Syndromes and Myeloproliferative Neoplasms]( [MEETING COVERAGE]( [Mid-Stage Win for Novel IgA Nephropathy Drug]( [SPECIAL REPORTS]( [Nurse Found Dead in Basement; Pain Doc Settles for $1.5M; Child Abuse Doc Testifies]( [HOSPITAL-BASED MEDICINE]( [Most Medical, Nursing Students Don't Plan to Treat Patients, Survey Finds]( CME SPOTLIGHT [Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: A Transformative Quality Improvement Initiative at a Large Community-Based Network]( [MEDICAL JOURNEYS]( [Case Study: Sudden Debilitating Fatigue, Difficulty Breathing in Man With Ulcerative Colitis]( CME SPOTLIGHT [Accelerating Adoption of Novel Therapies for Optimal Diffuse Large B-Cell Lymphoma Care]( # Weekly Survey [Should Eisen Have Been Fired?]( Some in academia have raised concerns that Michael Eisen, PhD, [lost his job at eLife]( over his social media posts about the Israel-Hamas conflict[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-11-02&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.